These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Glaucoma and Moscow Eye Microsurgery complex (Moroz) keratoprosthesis].
    Author: Yu JF, Huang YF, Wang LQ, Wang DJ.
    Journal: Zhonghua Yan Ke Za Zhi; 2013 Oct; 49(10):873-7. PubMed ID: 24433687.
    Abstract:
    OBJECTIVE: To investigate the relationship between glaucoma and Moscow Eye Microsurgery Complex (Moroz) keratoprosthesis. METHODS: Analysis and retrospective review of consecutive clinical case series. A total of 90 patients had a Moroz keratoprosthesis implantation between Apr, 2000 and Jun, 2011 at our hospital.Fifteen eyes of 15 patients were included in this research. Twelve eyes were identified glaucoma before Moroz keratoprosthesis surgery, and 3 eyes developed glaucoma afterward.Intraocular pressure (IOP), best-corrected visual acuity (BCVA), and treatment of glaucoma were recorded at 1 to 3 months after the Moroz keratoprosthesis implantation. RESULTS: Moroz keratoprosthesis surgery improved vision dramatically in the majority of patients in our study. The most common preoperative corneal diagnosis was alkali burn (8 eyes, 53.3%), which maybe the risk factor of secondary glaucoma after keratoprosthesis surgery.Five of these 15 patients received cyclocryotherapy after the surgery to control elevated IOP. BCVA decreased from 0.8 to 0.2, 0.25 to light perception, 0.3 to 0.1, 0.2 to hand movement, and 0.25 to counting fingers, respectively. CONCLUSIONS: Moroz keratoprosthesis caused glaucoma in only a small number of patients.Visual field, optic nerve appearance and IOP were the main diagnostic modalities after Moroz keratoprosthesis implantation.
    [Abstract] [Full Text] [Related] [New Search]